Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voclosporin single-cell RNA sequencing study in lupus nephritis
jRCTs041250131Recruiting
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of voclosporin in lupus nephritis (LN), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Change in peripheral immune cell RNA expression. Started Jan 2026; status: recruiting.
02
Drugs
voclosporin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on jRCTs041250131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041250131.